title: Neutrophil CD64 as a marker of infection in patients treated  with tocilizumab.
authors.affiliation: Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, 18-1 Sakuradai, Sagamihara, Kanagawa 228-8522, Japan. t-matsui@sagamihara-hosp.gr.jp
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Matsui
authors.forename: Akiko
authors.initials: A
authors.lastname: Komiya
authors.forename: Kota
authors.initials: K
authors.lastname: Shimada
authors.forename: Hisanori
authors.initials: H
authors.lastname: Nakayama
authors.forename: Shigeto
authors.initials: S
authors.lastname: Tohma
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000628:therapy; D015415:Biomarkers; D005260:Female; D006801:Humans; D007239:Infections / Q000276:immunology*; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D017452:Receptors, IgG; C502936:tocilizumab